Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Qsam Biosciences Inc
(OP:
QSAM
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Qsam Biosciences Inc
< Previous
1
2
Next >
Study Finds Epigenetics May Revolutionize Treatment of Cancer
November 01, 2022
Via
Investor Brand Network
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Approval of Second Clinical Trial Site for Phase 1 Study
October 26, 2022
Via
Investor Brand Network
Exposures
Product Safety
QSAM Biosciences Adds Rutgers Cancer Institute of New Jersey as Clinical Trial Site To Expand and Advance Study of CycloSam® in the Treatment of Bone Cancer
October 26, 2022
From
QSAM Biosciences Inc.
Via
GlobeNewswire
Researchers Develop Wireless Implant to Kill Cancer Cells in Brain Tumors
October 25, 2022
Via
Investor Brand Network
QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’
July 07, 2022
Via
Investor Brand Network
Cancer Studies Provide Researchers with New Information on Ovarian Cancer Development, Growth
October 18, 2022
Via
Investor Brand Network
New Report Praises Advances in Cancer Treatment for Preventing Millions of Deaths
October 11, 2022
Via
Investor Brand Network
Study Finds Antibiotics May Boost Melanoma Growth by Depleting Gut Microbiome
October 05, 2022
Via
Investor Brand Network
TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) Working to Make a Difference in Underserved Patient Populations
September 30, 2022
Via
Investor Brand Network
Exposures
Product Safety
Better Screening, Treatment Advances Have Reduced Cancer Fatalities
September 28, 2022
Via
Investor Brand Network
QSAM Biosciences Inc. (QSAM) Working to Halt, Regress Bone Tumors in Children Through Therapeutic Radiopharmaceuticals
September 20, 2022
Via
Investor Brand Network
Scientists Discover Unexpected Way in Which Air Pollution Causes Cancer
September 20, 2022
Via
Investor Brand Network
Researchers Find Cases of Osteosarcoma More Prevalent in Blacks
September 12, 2022
Via
Investor Brand Network
Research Suggests Some 50% of Cancers Result from Preventable Factors
September 01, 2022
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) Receives ‘Marketable Advantage’ Toward Manufacturing, Supply Chain of CycloSam(R)
August 25, 2022
Via
Investor Brand Network
Topics
Economy
Intellectual Property
Exposures
Intellectual Property
Product Safety
Supply Chain
Study Finds Patients with Hodgkin’s Lymphoma Have Higher Risk of Developing Mental Illnesses
August 24, 2022
Via
Investor Brand Network
New Study Plans to Eliminate Side Effects of Cancer Therapies in Children
August 17, 2022
Via
Investor Brand Network
QSAM Biosciences Inc. (QSAM) Awarded Patent for Potential Breakthrough Bone Cancer Treatment
August 16, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
BioMedNewsBreaks – QSAM Biosciences Inc. (OTCQB: QSAM) Releases Q2 2022 Financial Report, Corporate Update
August 16, 2022
Via
Investor Brand Network
Topics
Economy
Intellectual Property
Exposures
Intellectual Property
Product Safety
Supply Chain
Research Shows Access to Health Insurance Invaluable in Early Cancer Diagnosis
August 09, 2022
Via
Investor Brand Network
Study Discovers Common Mechanism Behind Cancer Metastasis, Cardiovascular Disease
August 01, 2022
Via
Investor Brand Network
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)
July 28, 2022
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks – Why QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’
July 22, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Researchers Have Found a New, Fatal Pediatric Subtype of Cancer
July 22, 2022
Via
Investor Brand Network
Scientists Identify Gene Behind Pediatric Bone Cancer
July 15, 2022
Via
Investor Brand Network
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) Expands IP Estate with Receipt of Third US Patent for CycloSam(R)
July 13, 2022
Via
Investor Brand Network
Topics
Economy
Intellectual Property
Exposures
Intellectual Property
Product Safety
Supply Chain
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.